Atropine Sulfate Injection Recalled for Glass Particulate Matter Contamination
Pfizer Inc. is recalling Atropine Sulfate Injection due to glass particulate matter contamination in lot GY2496. This FDA Class I recall affects 24,400 cartons distributed nationwide in the USA and Puerto Rico.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This recall is classified as FDA Class I, which per the severity rubric results in a minimum score of 4 (Severe). No deaths, hospitalizations, or injuries have been reported in the source text.
Plain-English summary
Pfizer Inc. is recalling Atropine Sulfate Injection, USP 1 mg/10 mL (0.1 mg/mL) in Lifeshield Glass ABBOJECT Unit of Use Syringes due to the presence of glass particulate matter. The affected product is lot GY2496 with an expiration date of February 1, 2025. This is an FDA Class I recall, the most serious category used by the FDA for drug recalls.
Approximately 24,400 cartons of the affected lot have been distributed nationwide in the United States and Puerto Rico. Healthcare facilities and patients who have received this product from the affected lot should cease use immediately.
Patients and healthcare providers who have questions about this recall or believe they may have this product should contact their healthcare provider or pharmacist. Pharmacies and healthcare facilities should review their inventory and contact Pfizer Inc. for return instructions and product replacement.
The recalled product
- Product
- ATROPINE SULFATE (ATROPINE SULFATE)
- Brand
- ATROPINE SULFATE
- Manufacturer
- Pfizer Inc.
- Affected units
- 24,400
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot GY2496
- Exp 02/01/2025
Distribution
Part of a larger recall action
This product is one of 3 recalled by Pfizer Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same brand · ATROPINE SULFATE
- SevereAmerican Regent Recalls Atropine Sulfate Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- ModerateFDA Class III Atropine Sulfate Ophthalmic Solution Recall for Specification Failures
FDA (Drugs) · 2025-01-08
- HighAccord Healthcare Recalls Atropine Sulfate Injection for Particulate Matter Contamination
FDA (Drugs) · 2023-07-19
Same manufacturer · Pfizer Inc.
See all →- HighEpinephrine injection vials recalled for lack of assurance of sterility
FDA (Drugs) · 2025-08-27
- HighSodium bicarbonate injection vials recalled for lack of assurance of sterility
FDA (Drugs) · 2025-08-27
- HighBicillin L-A penicillin vials recalled after particulates found during visual inspection
FDA (Drugs) · 2025-08-06
- HighBicillin L-A 2.4 million unit vials recalled after particulates found
FDA (Drugs) · 2025-08-06
- ModerateDobutamine Injection Recall Due to Discoloration and Cracked Vials
FDA (Drugs) · 2025-07-02
Same hazard · glass contamination
See all →- SevereOutshine Strawberry Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Tangerine Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Watermelon Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereAmerican Regent Recalls Cyanocobalamin Injections Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Acetylcysteine Solution Due to Particulate Matter
FDA (Drugs) · 2026-08-26